A critical advance in cancer investigation is occurring with the use of VHH fragments to re-engage dysfunctional p53. This essential cancer inhibitor protein is frequently lost in various forms of malignancies, causing https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research